Plenary #12: Psychedelics Research Panel / Scott Shannon, MD and Charles Raison, MD

Scott Shannon, MD, ABIHM, has been involved in holistic medicine since he joined the American Holistic Medical Association in 1978. Scott has elaborated a holistic and integrative perspective in psychiatry for the last two decades. He published the first textbook for this field in 2001. Scott is a past President of the American Holistic Medical Association and a past President of the American Board of Integrative Holistic Medicine. He was a founding Board member for the Academy of Integrative Health and Medicine and the American Board of Integrative Medicine, which is now the sole certifying body for the profession of Integrative Medicine. In 2010 he founded Wholeness Center, in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and cares for mental health concerns with 16 professionals in 10different disciplines. Norton published his latest textbook for professionals, Mental Health for the Whole Child in 2013 and his book for parents, Parenting the Whole Child in 2014. Scott serves as a site Principal Investigator and therapist for the phase III trial of MDMA assisted psychotherapy for PTSD sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). This study is coming full circle for Scott as he worked with MDMA legally in his practice before the DEA scheduled it in 1985. He has published numerous articles about his research on cannabidiol in mental health based on the extensive application of this new tool at his clinic in Colorado. Teaching has been a core component of Scott's life. He teaches as an Assistant Clinical Professor of Psychiatry at the University of Colorado-Children’s Hospital in Denver. In 2004 the University of Colorado became the first American training program to offer a formal elective in Integrative Child and Adolescent Psychiatry. He helped to develop the current integrative training track for psychiatry residents at the University of Colorado. Currently, Scott works extensively with ketamine and ketamine-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about how to offer transformative care. Charles Raison, MD, is the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, WI. Dr. Raison also serves as Director of Clinical and Translational Research for Usona Institute and as Director of Research on Spiritual Health for Emory Healthcare in Atlanta, GA. In addition, Dr. Raison has served as mental health expert for for many years. Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. More recently, Dr. Raison has taken a leadership role in the development of psychedelic medicines as potential treatments for major depression. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association “in recognition of his contributions to our understanding of evolutionary biocultural origins of mental health and illness.” With Vladimir Maletic he is author of “The New Mind-Body Science of Depression” published by W.W. Norton in 2017. Dr. Raison serves on the Scientific Advisory Board for the American Foundation for Suicide Prevention.